1. Home
  2. IVA vs OPI Comparison

IVA vs OPI Comparison

Compare IVA & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • OPI
  • Stock Information
  • Founded
  • IVA 2011
  • OPI 2009
  • Country
  • IVA France
  • OPI United States
  • Employees
  • IVA N/A
  • OPI N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • OPI Real Estate Investment Trusts
  • Sector
  • IVA Health Care
  • OPI Real Estate
  • Exchange
  • IVA Nasdaq
  • OPI Nasdaq
  • Market Cap
  • IVA 117.3M
  • OPI 105.1M
  • IPO Year
  • IVA 2020
  • OPI 2009
  • Fundamental
  • Price
  • IVA $2.35
  • OPI $1.02
  • Analyst Decision
  • IVA Strong Buy
  • OPI Buy
  • Analyst Count
  • IVA 4
  • OPI 2
  • Target Price
  • IVA $13.25
  • OPI $4.30
  • AVG Volume (30 Days)
  • IVA 9.3K
  • OPI 1.5M
  • Earning Date
  • IVA 09-25-2024
  • OPI 02-13-2025
  • Dividend Yield
  • IVA N/A
  • OPI 3.92%
  • EPS Growth
  • IVA N/A
  • OPI N/A
  • EPS
  • IVA N/A
  • OPI N/A
  • Revenue
  • IVA $20,652,523.00
  • OPI $517,514,000.00
  • Revenue This Year
  • IVA N/A
  • OPI N/A
  • Revenue Next Year
  • IVA $361.78
  • OPI N/A
  • P/E Ratio
  • IVA N/A
  • OPI N/A
  • Revenue Growth
  • IVA N/A
  • OPI N/A
  • 52 Week Low
  • IVA $1.53
  • OPI $1.02
  • 52 Week High
  • IVA $4.75
  • OPI $7.53
  • Technical
  • Relative Strength Index (RSI)
  • IVA 36.64
  • OPI 29.66
  • Support Level
  • IVA $2.22
  • OPI $1.32
  • Resistance Level
  • IVA $2.39
  • OPI $1.99
  • Average True Range (ATR)
  • IVA 0.10
  • OPI 0.10
  • MACD
  • IVA -0.03
  • OPI -0.03
  • Stochastic Oscillator
  • IVA 24.76
  • OPI 0.00

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About OPI Office Properties Income Trust of Beneficial Interest

Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its largest tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.

Share on Social Networks: